MustGrow Biologics Corp.
MGRO.V · TSXV
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | CA$0 | CA$0 | CA$0 | CA$0 |
| % Growth | -72.3% | -24.7% | 3,082.3% | – |
| Cost of Goods Sold | CA$0 | CA$0 | CA$0 | CA$0 |
| Gross Profit | CA$0 | CA$0 | CA$0 | CA$0 |
| % Margin | 21.2% | 20.9% | 14.3% | 21.3% |
| R&D Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| G&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| SG&A Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Sales & Mktg Exp. | CA$0 | CA$0 | CA$0 | CA$0 |
| Other Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Expenses | CA$0 | CA$0 | CA$0 | CA$0 |
| Operating Income | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -306.9% | -34.2% | -39% | -1,045.6% |
| Other Income/Exp. Net | -CA$0 | -CA$0 | -CA$0 | CA$0 |
| Pre-Tax Income | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| Tax Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Net Income | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -307.9% | -38.2% | -43.4% | -1,020.8% |
| EPS | -0.044 | -0.021 | -0.032 | -0.024 |
| % Growth | -112.4% | 34.3% | -35.3% | – |
| EPS Diluted | -0.044 | -0.021 | -0.032 | -0.024 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | CA$0 | CA$0 | CA$0 | CA$0 |
| Interest Expense | CA$0 | CA$0 | CA$0 | CA$0 |
| Depreciation & Amortization | CA$0 | CA$0 | CA$0 | -CA$0 |
| EBITDA | -CA$0 | -CA$0 | -CA$0 | -CA$0 |
| % Margin | -305% | -35.9% | -42% | -1,045.6% |